Search Within

Mary Louise Keohan

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (33)
  2. Journal Article (25)
Groups
  1. Biostatistics Service (58)
  2. Department of Medicine (58)
  3. Epidemiology and Biostatistics (58)
  4. Sarcoma Service (58)
  5. Solid Tumor Oncology Division (58)
  6. Hematologic Malignancies, Division of (52)

More Groups

People
  1. Li-Xuan Qin (54)
  2. Mark Dickson (53)
  3. William Tap (53)
  4. Sandra D'Angelo (52)
  5. Mrinal Gounder (51)
  6. Ping Chi (42)

More People

Years
  1. 2025 (1)
  2. 2024 (7)
  3. 2023 (6)
  4. 2022 (8)
  5. 2021 (1)
  6. 2020 (6)

More Years

Publications
  1. Journal of Clinical Oncology (32)
  2. Clinical Cancer Research (7)
  3. Annals of Oncology (3)
  4. The Oncologist (3)
  5. Annals of Surgical Oncology (2)
  6. British Journal of Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (33)
  2. American Association for Cancer Research (8)
  3. Oxford University Press (6)
  4. Elsevier Inc. (3)
  5. Springer (3)
  6. Nature Publishing Group (2)

More Publishers

Results (58)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Poor prognostic features in angiosarcoma: A single institution retrospective study of 324 patients
    Meeting Abstract

    D'Angelo, S. P.; Moraco, N. H.; Qin, L. X.; Kuk, D.; Carvajal, R. D.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Antonescu, C. R.; Singer, S.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • High-risk features in radiation-associated breast angiosarcomas
    Journal Article

    D'Angelo, S. P.; Antonescu, C. R.; Kuk, D.; Qin, L.; Moraco, N.; Carvajal, R. D.; Chi, P.; Dickson, M. A.; Gounder, M.; Keohan, M. L.; more...
    British Journal of Cancer (2013)

    Fulltext@MSK | Save
  • Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma
    Journal Article

    Dickson, M. A.; Tap, W. D.; Keohan, M. L.; D'Angelo, S. P.; Gounder, M. M.; Antonescu, C. R.; Landa, J.; Qin, L. X.; Rathbone, D. D.; Condy, M. M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Adult rhabdomyosarcoma survival improved with treatment on multimodality protocols
    Journal Article

    Gerber, N. K.; Wexler, L. H.; Singer, S.; Alektiar, K. M.; Keohan, M. L.; Shi, W.; Zhang, Z.; Wolden, S.
    International Journal of Radiation Oncology, Biology, Physics (2013)

    Fulltext@MSK | Save
  • A first-in-human, phase Ib combination study to assess safety, pharmacokinetics (PK), and pharmacodynamics (PD) of a hedgehog inhibitor, GDC-0449, with a Notch inhibitor, RO4929097, in patients with advanced sarcoma
    Meeting Abstract

    Gounder, M. M.; Dickson, M. A.; Wu, N.; Ivy, S. P.; Carvajal, R. D.; D'Angelo, S. P.; Keohan, M. L.; Qin, L. X.; Erinjeri, J. P.; Takebe, N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of the CDK4 inhibitor PD0332991 in CDK4-amplified liposarcoma
    Meeting Abstract

    Dickson, M. A.; Keohan, M. L.; Tap, W. D.; Antonescu, C.; Landa, J.; Qin, L. X.; Dohrenwend, E. G.; Rathbone, D.; Ustoyev, Y.; Condy, M. M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase II trial of sorafenib (S) and dacarbazine (D) in leiomyosarcoma (LMS), synovial sarcoma (SS), and malignant peripheral nerve sheath tumor (MPNST)
    Meeting Abstract

    D'Adamo, D. R.; Keohan, M. L.; Carvajal, R. D.; Hensley, M. L.; Hirst, C.; Qin, L.; Antonescu, C.; Lefkowitz, R. A.; Schwartz, G. K.; Maki, R. G.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of sorafenib in patients with metastatic or recurrent sarcomas
    Journal Article

    Maki, R. G.; D'adamo, D. R.; Keohan, M. L.; Saulle, M.; Schuetze, S. M.; Undevia, S. D.; Livingston, M. B.; Cooney, M. M.; Hensley, M. L.; Mita, M. M.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save